loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 4d422694 0935 46d3 A24d 678aada0d17b Applno 206073 Form Tablet Oral Dosage 10mg 5mg - Drug Product Composition: (2S,3R,4R,5S,6R)-2-[4-CHLORO-3-[[4-[(3S)-OXOLAN-3-YL]OXYPHENYL]METHYL]PHENYL]-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL

    Menu

    (2S,3R,4R,5S,6R)-2-[4-CHLORO-3-[[4-[(3S)-OXOLAN-3-YL]OXYPHENYL]METHYL]PHENYL]-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,782Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 206073 / DOSAGE - TABLET;ORAL - 10MG;5MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EMPAGLIFLOZIN(UNII: HDC1R2M35U)
    (EMPAGLIFLOZIN - UNII:HDC1R2M35U)     		EMPAGLIFLOZIN10mg
    LINAGLIPTIN(UNII: 3X29ZEJ4R2)
    (LINAGLIPTIN - UNII:3X29ZEJ4R2)     		LINAGLIPTIN5mg